Completed NA INTERVENTIONAL 3-arm NCT01898195

Improving Adherence to Smoking Cessation Medication Among PLWHA (HIV)

Sponsor: NYU Langone Health

Interventions Adherence Behavioral Therapy Text Message Varenicline

Updated 8 times since 2017 Last updated: Jul 19, 2017 Started: Mar 31, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01898195, this NA trial focuses on Tobacco Use Cessation and remains completed. Sponsored by NYU Langone Health, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Jun 2019 [monthly]

Completed NA

▶ Show 3 earlier versions

Sep 2017 — Jun 2018 [monthly]

Completed NA
Feb 2017 — Sep 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NYU Langone Health

Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States